Evaluate the Safety of Linaclotide in IBS-C Patients in China
NCT04462900 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3028
Last updated 2024-05-13
Summary
This is a Multi-center, single arm, observational study to evaluate the safety of linaclotide in IBS-C patients in China. Enrolls approximately 3,000 Chinese patients from 30 participating sites around China and followed up for half year.
Conditions
- Irritable Bowel Syndrome-IBS
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-18
- Primary Completion
- 2023-02-03
- Completion
- 2023-02-03
Countries
- China
Study Locations
More Related Trials
-
Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China
NCT02955316 ·Status: COMPLETED
-
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
NCT00730171 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation
NCT00948818 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT00938717 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
NCT02316899 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
NCT02559817 ·Status: TERMINATED ·Phase: PHASE2
-
Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients
NCT02078323 ·Status: COMPLETED ·Phase: NA
-
IBS-C Questionnaire Study
NCT04968652 ·Status: COMPLETED
-
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT02559206 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT02837783 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
NCT01714843 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive and Psychiatric Effects of Linaclotide on Patients With Constipation
NCT03342287 ·Status: WITHDRAWN
-
52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT02120027 ·Status: TERMINATED ·Phase: PHASE3
-
Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
NCT04166058 ·Status: COMPLETED ·Phase: PHASE3
-
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT02107196 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Safety Study of Plecanatide
NCT02706483 ·Status: COMPLETED ·Phase: PHASE3
-
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT02320318 ·Status: WITHDRAWN ·Phase: PHASE3
-
Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)
NCT04043455 ·Status: TERMINATED ·Phase: PHASE2
-
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
NCT02493452 ·Status: COMPLETED ·Phase: PHASE3
-
Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome
NCT00813098 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
NCT03977155 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effect of SYN-010 on Subjects With IBS-C
NCT02495623 ·Status: COMPLETED ·Phase: PHASE2
-
Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)
NCT00101985 ·Status: COMPLETED ·Phase: PHASE2
-
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
NCT01722318 ·Status: COMPLETED ·Phase: PHASE2